Eidgenössische Ethikkommission für die Biotechnologie im Ausserhumanbereich EKAH

-»This version is meant for browsers without CSS support mainly for visually disabled users. For a more advanced layout please use a more recent browser like Firefox 2.0 or Internet Explorer 7.«-

Begin language selection

Begin main navigation

Begin sub navigation

Begin navigator

Homepage  >  The Committee  >  Gene Therapy Working G...

 



Begin content area

Gene Therapy Working Group

The SECB's Gene Therapy Working Group is responsible for evaluating experimental gene therapy.

Members of the Gene Therapy Working Group

Chair

  • Meylan Pascal, Prof. MD, Institut de Microbiologie de l'Université de Lausanne

Members (external experts)

  • Carlo V. Catapano, MD, PhD, Oncology Institute of Southern Switzerland, Bellinzona
  • Karoline Dorsch, PhD, Männedorf
  • Phillipe Paroz, PhD, Crucell AG, Bern
  • Jean-Claude Piffaretti, Prof. PhD, Interlifescience, Massagno,
  • Pedro Romero, Prof. MD, Ludwig Institute for Cancer Research, Lausanne
  • Sandro Rusconi, Prof. PhD, Repubblica e Cantone Ticino, Divisione della Cultura e degli Studi Universitari, Bellinzona

Last updated on: 07.02.2012




Contact

  • Swiss Expert Committee for Biosafety (SECB)
    Tel.: +41 (0)31 323 03 55
    Tel.: +41 (0)31 323 23 12
    Fax: +41 (0)31 323 03 69
    info@dont-want-spamefbs.admin.ch
  • Postal address
    Executive Office SECB
    c/o Federal Office for the Environment
    CH-3003 Bern
  • Location of our office
    Worblentalstrasse 68
    3063 Ittigen


Swiss Expert Committee for Biosafety SECB
info@efbs.admin.ch | Limitation of liability, Data protection and Copyright
http://www.efbs.ch/index.php?id=78